BRANMOOR
THURSDAY ยท 14 MAY 2026

FDA Recall D-0221-2026

Fagron Compounding Services · Wichita, KS

Class II Ongoing 175 days on record

Moderate impact — Class II recall โ€” temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.

Product

Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01

Lot / code: Lot#: C274-000047958; Exp. December 19, 2025

Quantity: 2980 syringes

Reason for recall

Incorrect Product Formulation

Recall record

Recall number
D-0221-2026
Classification
Class II
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Letter
Distribution
U.S. Nationwide.
Recall initiated
2025-11-20
Classified by FDA Center
2025-12-08
FDA published
2025-12-17
Recalling firm
Fagron Compounding Services
Firm location
Wichita, KS

Operational response

Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls